Global Next-Generation Sequencing eDNA Biomonitoring Market Strategic Research Report
By Type: Targeted Sequencing & Resequencing, Whole Genome Sequencing, Whole Exome Sequencing
By Application: Water, Soil, Air, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Illumina, Inc, Stantec, Eurofins Genomics, Spygen, ID-Gene Ecordiagnostics, EnviroDNA, eDNAtec, Genidaqs, NatureMetrics, Jonah Ventures, Sinsoma GmbH, SimplexDNA
Visão geral
Scope of the Report
The global Next-Generation Sequencing eDNA Biomonitoring market size is predicted to grow from US$ 24.98 million in 2025 to US$ 43.49 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.
Next-generation sequencing technology, also known as high-throughput sequencing technology or new generation sequencing technology, can split DNA samples into thousands of tiny fragments, and quickly read them through high-throughput sequencers, and finally splice out a complete DNA sequence. This technology has the advantages of high throughput, low cost and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring.
High-throughput sequencing technology (i.e., next-generation sequencing technology) has the advantages of high throughput, low cost, and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring. These technological advances have made DNA biomonitoring more efficient and accurate, thereby driving the growth of the market. On the other hand, with the development of bioinformatics, the ability to analyze and interpret sequencing data is also constantly improving. This helps to extract valuable information from massive sequencing data and provide more accurate data support for environmental monitoring, disease diagnosis, etc.
With the continuous improvement of people's awareness of environmental protection, the demand for monitoring environmental DNA (eDNA) is also increasing. By monitoring DNA in the environment, we can understand the health of the ecosystem and promptly detect and respond to potential ecological problems. In the medical field, DNA sequencing technology is also widely used in disease diagnosis and prevention. By sequencing and analyzing individual genomes, the risk of individual illness can be predicted, providing strong support for early prevention and treatment of diseases. This demand has also driven the development of the next-generation sequencing environmental DNA biomonitoring market.
Although next-generation sequencing technology has made significant progress, there are still some technical challenges and limitations. For example, the accuracy and sensitivity of sequencing need to be further improved to better meet the needs of environmental monitoring and disease diagnosis. The amount of data generated by sequencing is huge, and contains a lot of redundant and erroneous information. How to extract valuable information from massive data is a technical problem currently faced. In addition, data analysis also requires professional knowledge and skills, which increases the complexity and cost of the operation.
In addition, although the cost of next-generation sequencing technology has been greatly reduced, it is still a considerable expense for some small laboratories or research institutions. The high cost of sequencing limits the widespread application and promotion of the technology.
Although the next-generation sequencing environmental DNA biomonitoring technology has broad application prospects, the current market awareness of it is not high. Some potential customers may take a wait-and-see attitude towards this new technology, waiting for it to further mature and popularize. Customers in different fields and industries have different acceptance of technology. Some fields may prefer to adopt traditional monitoring methods and technologies, and are less willing to try new sequencing technologies.
This report presents a comprehensive overview of the global Next-Generation Sequencing eDNA Biomonitoring market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Targeted Sequencing & Resequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
Segment by Application
- Water
- Soil
- Air
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Next-Generation Sequencing eDNA Biomonitoring market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Water, Soil, Air evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Next-Generation Sequencing eDNA Biomonitoring Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Targeted Sequencing & Resequencing
- 3.1.3 Whole Genome Sequencing
- 3.1.4 Whole Exome Sequencing
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Water
- 4.1.3 Soil
- 4.1.4 Air
- 4.1.5 Others
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Illumina, Inc
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Stantec
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Eurofins Genomics
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Spygen
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 ID-Gene Ecordiagnostics
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 EnviroDNA
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 eDNAtec
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Genidaqs
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 NatureMetrics
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Jonah Ventures
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Sinsoma GmbH
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 SimplexDNA
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Next-Generation Sequencing eDNA Biomonitoring market?
What is the forecast CAGR for the Next-Generation Sequencing eDNA Biomonitoring market?
What is Next-Generation Sequencing eDNA Biomonitoring?
What are the main segments of the Next-Generation Sequencing eDNA Biomonitoring market by type?
Which applications drive demand in the Next-Generation Sequencing eDNA Biomonitoring market?
Who are the key players in the Next-Generation Sequencing eDNA Biomonitoring market?
Which regions and countries are covered for Next-Generation Sequencing eDNA Biomonitoring?
What is driving growth in the Next-Generation Sequencing eDNA Biomonitoring market?
What challenges does the Next-Generation Sequencing eDNA Biomonitoring market face?
Who should buy the Next-Generation Sequencing eDNA Biomonitoring market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Next-Generation Sequencing eDNA Biomonitoring Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Biotechnology & Life Sciences